The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of WTX212, an erythrocyte-anti-PD1 antibody conjugate, in anti-tumor activities in tumor models and cancer patients with acquired resistance to immunotherapy.
 
Xiaoqian Nie
No Relationships to Disclose
 
Yuehua Liu
No Relationships to Disclose
 
Gao Xiaofei
Employment - Westlake Therapeutics
Leadership - Westlake Therapeutics
Stock and Other Ownership Interests - Westlake Therapeutics
Patents, Royalties, Other Intellectual Property - 1. METHOD FOR PREPARING MATURE RED BLOOD CELLS IN VITRO USING PERIPHERAL BLOOD; US17/430020; Inventors: Xiaofei Gao, Yanjie Huang, Qing Zhang. 2. GENETICALLY ENGINEERED ERYTHROCYTES CARRYING ANTI-PD-1 SINGLE CHAIN ANTIBODY AND PREPARATION METHOD THEREFOR;
Travel, Accommodations, Expenses - Westlake Therapeutics; Westlake Therapeutics
 
Qi Zhang
No Relationships to Disclose
 
Li Xu
No Relationships to Disclose
 
Yanjie Huang
No Relationships to Disclose
 
Yang Yuan
No Relationships to Disclose
 
Jiawei Zheng
No Relationships to Disclose